Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Interest Expenses (2023 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Interest Expenses for 3 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 11.56% year-over-year to $2.1 million, compared with a TTM value of $7.9 million through Dec 2025, up 6.64%, and an annual FY2025 reading of $7.9 million, up 6.64% over the prior year.
  • Interest Expenses was $2.1 million for Q4 2025 at Tandem Diabetes Care, roughly flat from $2.1 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $2.1 million in Q4 2025 and bottomed at $1.6 million in Q2 2023.
  • Average Interest Expenses over 3 years is $1.9 million, with a median of $1.9 million recorded in 2024.
  • The sharpest move saw Interest Expenses rose 11.71% in 2024, then decreased 1.85% in 2025.
  • Year by year, Interest Expenses stood at $1.8 million in 2023, then grew by 3.16% to $1.9 million in 2024, then increased by 11.56% to $2.1 million in 2025.
  • Business Quant data shows Interest Expenses for TNDM at $2.1 million in Q4 2025, $2.1 million in Q3 2025, and $1.9 million in Q2 2025.